|
Medical News -
Cardiovascular and Cardiology
|
|
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that the U.S. Food and Drug Administration (FDA) has cleared for marketing the CARTO® 3 System, the most advanced three-dimensional imaging technology for use by electrophysiologists in treating cardiac arrhythmias, commonly referred to as irregular heart rhythms. It is estimated that 20 million people in the United States suffer from some sort of arrhythmia. Read more:
|
